Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Oxford, UK.
Eur J Heart Fail. 2021 Jan;23(1):3-12. doi: 10.1002/ejhf.1996. Epub 2020 Sep 23.
To understand gender differences in the prognosis of women and men with heart failure, we compared mortality, cause of death and survival trends over time.
We analysed UK primary care data for 26 725 women and 29 234 men over age 45 years with a new diagnosis of heart failure between 1 January 2000 and 31 December 2017 using the Clinical Practice Research Datalink, inpatient Hospital Episode Statistics and the Office for National Statistics death registry. Age-specific overall survival and cause-specific mortality rates were calculated by gender and year. During the study period 15 084 women and 15 822 men with heart failure died. Women were on average 5 years older at diagnosis (79.6 vs. 74.8 years). Median survival was lower in women compared to men (3.99 vs. 4.47 years), but women had a 14% age-adjusted lower risk of all-cause mortality [hazard ratio (HR) 0.86, 95% confidence interval (CI) 0.84-0.88]. Heart failure was equally likely to be cause of death in women and men (HR 1.03, 95% CI 0.96-1.12). There were modest improvements in survival for both genders, but these were greater in men. The reduction in mortality risk in women was greatest for those diagnosed in the community (HR 0.83, 95% CI 0.80-0.85).
Women are diagnosed with heart failure older than men but have a better age-adjusted prognosis. Survival gains were less in women over the last two decades. Addressing gender differences in heart failure diagnostic and treatment pathways should be a clinical and research priority.
为了了解女性和男性心力衰竭患者预后的性别差异,我们比较了死亡率、死因和随时间推移的生存趋势。
我们分析了 2000 年 1 月 1 日至 2017 年 12 月 31 日期间年龄在 45 岁以上、新诊断为心力衰竭的 26725 名女性和 29234 名男性的英国初级保健数据,这些数据来自临床实践研究数据链接、住院患者病例统计和国家统计局死亡登记处。按性别和年份计算了特定年龄的总生存率和特定死因的死亡率。在研究期间,15084 名女性和 15822 名男性心力衰竭患者死亡。女性诊断时的平均年龄大 5 岁(79.6 岁对 74.8 岁)。与男性相比,女性的中位生存期较低(3.99 年对 4.47 年),但女性的全因死亡率风险低 14%(风险比[HR]0.86,95%置信区间[CI]0.84-0.88)。女性和男性心力衰竭同样可能是死因(HR 1.03,95%CI 0.96-1.12)。两性的生存状况都有所改善,但男性的改善幅度更大。对于在社区中诊断的女性,死亡率风险降低幅度最大(HR 0.83,95%CI 0.80-0.85)。
女性诊断心力衰竭的年龄大于男性,但调整年龄后的预后较好。在过去的二十年中,女性的生存获益较小。解决心力衰竭诊断和治疗途径中的性别差异应成为临床和研究的重点。